NEVVI Medicare utilization intelligence

← back

ZUHOSKI, ALEXANDERMD NPI 1992740856 Clinician

Medical Oncology · RIVERHEAD, NY

Specialty Medical Oncology — from billed Medicare claims
Trained STATE UNIVERSITY OF NEW YORK AT STONY BROOK, SCHOOL OF MEDICINE — medical school, self-reported to CMS
In practice about 29 years since medical school (class of 1997, self-reported to CMS)
Location RIVERHEAD, NY · NPPES registered location
Active in data Billed Medicare 2020–2024 (5 consecutive years)
Scale 115 codes billed · 237,180 disclosed services (CY2024 — most recent year in data)
Current groups

Group affiliation since 2019

20192026
NORTH SHORE HEMATOLOGY ONCOLOGY ASSOCIATES PC
2019–2026

The roster archive begins in 2019, so a span starting at 2019 may reach back further. Membership spans only — no volume is attributed to any group here.

NPPES registry · CMS Doctors & Clinicians registry · Medicare Part B physician/supplier claims · NPPES record last updated 2020-02

Year: 2024 · 2023 · 2022  · 2021  · 2020 

Provider overview · all codes · CY2024

The full analytics for this provider

Premium

The billed-volume positioning, practice focus, and economics behind this provider — computed on the same disclosed Medicare Part B data.

This provider's disclosed Medicare payments across all codes were in CY2024. Included with Platform.

  • Payment, service & beneficiary totals — the disclosed scale, all codes
  • Practice profile — focus & reach — top codes by share of services
  • Office vs. facility setting mix — place-of-service code split
  • Volume over five years — discrete yearly counts, no rate
  • Peer positioning — service volume — percentile among specialty peers, cohort & year disclosed
  • Peer positioning — code breadth — how many codes billed, vs peers

Peer positioning shows billed-volume and code-breadth positions among specialty peers, not measures of care (a provider's true volume position can only be higher, never lower). All figures disclosed Medicare Part B fee-for-service; volumes are personal to this NPI, not attributed to any group.

Notify me at launch → Or see a live example profile →

Procedures billed to Medicare Part B (2024)

Medicare Part B FFS · CY2024 · as published by CMS
CodeDescription Services Beneficiary-episodes Avg charge Avg Medicare payment
J1439 Injection, ferric carboxymaltose, 1 mg
J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use)
J9271 Injection, pembrolizumab, 1 mg
J1756 Injection, iron sucrose, 1 mg
J0897 Injection, denosumab, 1 mg
J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
J2796 Injection, romiplostim, 10 micrograms
36415 Insertion of needle into vein for collection of blood sample
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count
88185 Flow cytometry technique for dna or cell analysis, each additional marker
80053 Blood test, comprehensive group of blood chemicals
J1100 Injection, dexamethasone sodium phosphate, 1 mg
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
82784 Gammaglobulin (immune system protein) measurement
83615 Lactate dehydrogenase (enzyme) level
84100 Phosphate level
83735 Magnesium level
84550 Uric acid level, blood
82728 Ferritin (blood protein) level
83550 Iron binding capacity
83540 Iron level
99490 Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month
96372 Injection of drug or substance under skin or into muscle
83521 Measurement of immunoglobulin light chains
99215 Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
82607 Cyanocobalamin (vitamin b-12) level
J0640 Injection, leucovorin calcium, per 50 mg
96375 Injection of additional new drug or substance into vein
82378 Carcinoembryonic antigen (cea) protein level
J9190 Injection, fluorouracil, 500 mg
82306 Vitamin d-3 level
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less
85044 Red blood count, manual test
96367 Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less
84443 Blood test, thyroid stimulating hormone (tsh)
96413 Administration of chemotherapy into vein, 1 hour or less
96366 Infusion into a vein for therapy, prevention, or diagnosis, each additional hour
84153 Psa (prostate specific antigen) measurement, total
82746 Folic acid level, serum
J1200 Injection, diphenhydramine hcl, up to 50 mg
J9045 Injection, carboplatin, 50 mg
J3475 Injection, magnesium sulfate, per 500 mg
86334 Immunologic analysis technique on serum (immunofixation)
82232 Beta-2 microglobulin (protein) level
96374 Injection of drug or substance into vein
84439 Thyroxine (thyroid chemical), free
86300 Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3
J3480 Injection, potassium chloride, per 2 meq
85610 Blood test, clotting time
88184 Flow cytometry technique for dna or cell analysis, first marker
96361 Infusion into a vein for hydration, each additional hour
84165 Protein measurement, serum
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes
J2405 Injection, ondansetron hydrochloride, per 1 mg
99426 Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month
99211 Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
96417 Administration of additional new drug or substance into vein, 1 hour or less
96360 Infusion into a vein for hydration, 31-60 minutes
83036 Hemoglobin a1c level
82533 Cortisol (hormone) measurement, total
96415 Administration of chemotherapy into vein, each additional hour
81002 Urinalysis, manual test
85651 Red blood cell sedimentation rate, to detect inflammation, non-automated
J1335 Injection, ertapenem sodium, 500 mg
84436 Thyroxine (thyroid chemical), total
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
J7030 Infusion, normal saline solution , 1000 cc
96402 Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle
J1454 Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
83090 Homocysteine (amino acid) level
99205 New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
99195 Drawing of blood for a medical problem
84403 Testosterone (hormone) level, total
96401 Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle
83010 Haptoglobin (serum protein) level
J7050 Infusion, normal saline solution, 250 cc
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit)
96411 Administration of additional new drug or substance into vein using push technique
86147 Cardiolipin antibody (tissue antibody) measurement
82668 Erythropoietin (protein) level
80074 Acute hepatitis panel
86304 Immunologic analysis for detection of tumor antigen, quantitative; ca 125
86146 Beta 2 glycoprotein 1 antibody (autoantibody) measurement
80061 Blood test, lipids (cholesterol and triglycerides)
82248 Bilirubin level, direct
G0498 Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l
G0008 Administration of influenza virus vaccine
85379 Coagulation function measurement, d-dimer; quantitative
83970 Parathormone (parathyroid hormone) level
90662 Influenza vaccine split virus, preservative free
99496 Transitional care management services for problem of high complexity
80047 Blood test, basic group of blood chemicals (calcium, ionized)
82785 Ige (immune system protein) level
85730 Coagulation assessment blood test, plasma or whole blood
86301 Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9
86618 Analysis for antibody borrelia burgdorferi (lyme disease bacteria)
86431 Rheumatoid factor level
99439 Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month
80307 Testing for presence of drug, by chemistry analyzers
82270 Stool analysis for blood to screen for colon tumors
80048 Blood test, basic group of blood chemicals (calcium, total)
82550 Creatine kinase (cardiac enzyme) level, total
96523 Irrigation of implanted venous access drug delivery device
85014 Red blood cell concentration measurement
86038 Screening test for autoimmune disorder
G0452 Molecular pathology procedure; physician interpretation and report
81219 Gene analysis (calreticulin), common variants
81270 Gene analysis (janus kinase 2) variant
81279 Gene analysis (janus kinase 2) targeted sequence analysis
81338 Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants
86141 Measurement c-reactive protein for detection of infection or inflammation, high sensitivity
82465 Cholesterol level
84478 Triglycerides level
J2175 Injection, meperidine hydrochloride, per 100 mg
87389 Detection test by immunoassay technique for hiv-1 antigen and hiv-1 and hiv-2 antibodies

These are this provider's own Medicare Part B fee-for-service volumes (CMS public data). CMS suppresses rows with fewer than 11 beneficiaries, so low-volume codes may be missing entirely — absence is not zero. Beneficiary-episodes count CMS's per-setting beneficiary figures, not unique patients. Average charge and average Medicare payment are weighted by service volume across office and facility settings. Volumes on this page are personal to the NPI and are not attributed to any physician group. See Methods & Sources.